LSD1 antibody (C-Term)
Quick Overview for LSD1 antibody (C-Term) (ABIN1907607)
Target
See all LSD1 (KDM1A) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- Region between residues 825 and the C-terminus (residue 886) of human FAD-binding protein BRAF35-HDAC complex 110 kD (lysine-specific histone demethylase 1) using the numbering given in TrEMBL entry O60341 (GeneID 23028).
-
Purification
- Immunoaffinity purified
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Approved: IF (1:50 - 1:500), IHC, IHC-P (1:500 - 1:2000), WB (1:5000 - 1:15000)
Usage: Immunohistochemistry: Antigen retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Tris-citrate/phosphate buffer, pH 7-8, 0.09 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store at 2-8°C for up to 1 year.
-
Expiry Date
- 12 months
-
-
- LSD1 (KDM1A) (Lysine (K)-Specific Demethylase 1A (KDM1A))
-
Alternative Name
- KDM1A / LSD1
-
Background
-
Name/Gene ID: KDM1A
Synonyms: KDM1A, BHC110, KDM1, LSD1, AOF2, KIAA0601 -
Gene ID
- 23028
-
Pathways
- Regulation of Hormone Metabolic Process, Regulation of Hormone Biosynthetic Process, Negative Regulation of intrinsic apoptotic Signaling, Warburg Effect
Target
-